Fecal Microbiota Transplant in Cirrhosis Reduces Gut Microbial Antibiotic Resistance Genes: Analysis of Two Trials

Jasmohan S. Bajaj, Amirhossein Shamsaddini, Andrew Fagan, Richard K. Sterling, Edith Gavis, Alexander Khoruts, Michael Fuchs, Hannah Lee, Masoumeh Sikaroodi, Patrick M. Gillevet – 21 November 2020 – Antibiotic resistance leads to poor outcomes in cirrhosis. Fecal microbiota transplant (FMT) is associated with reduction in antibiotic resistance gene (ARG) burden in patients without cirrhosis; however, the impact in cirrhosis is unclear.

Programmed Death Ligand 1 Is Overexpressed in Liver Macrophages in Chronic Liver Diseases, and Its Blockade Improves the Antibacterial Activity Against Infections

Elisa Pose, Mar Coll, Celia Martínez‐Sánchez, Zhutian Zeng, Bas G. J. Surewaard, Cristina Català, María Velasco‐de Andrés, Juan José Lozano, Sílvia Ariño, David Fuster, Aida Niñerola‐Bazán, Isabel Graupera, Érica Muñoz, Francisco Lozano, Pau Sancho‐Bru, Paul Kubes, Pere Ginès – 20 November 2020

Subscribe to